Protagenic Therapeutics- Warrants (13/04/2025) Other Current Liabilities

As of the most recent data (June 2026), PTIXW shows a other current liabilities of $73K. That compares with $4.4M in the prior-year period — down 98.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PTIXW's other current liabilities is now $73K (was $4.4M) — a 98.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Protagenic Therapeutics- Warrants (13/04/2025) is outperforming or lagging.

Tracking PTIXW's other current liabilities over time shows whether Protagenic Therapeutics- Warrants (13/04/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $73K That compares with $4.4M in the prior-year period — down 98.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Protagenic Therapeutics- Warrants (13/04/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $73K) with ownership activity and broader fundamentals.

Protagenic Therapeutics- Warrants (13/04/2025)'s other current liabilities is $73K; compare it with other Industrials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.